The reversal effect of GS-9973 in NCI-H460/MX20 cancer cells could be a change in the subcellular localization of ABCG2 from the cell membrane (i.e., the transporter would not be in the cell membrane, producing a decrease in drug efflux from the cells). The gene discussed is ABCG2; the disease is cancer.